Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 17145622)

Published in Am J Clin Pathol on January 01, 2007

Authors

X Frank Zhao1, Ken H Young, Dale Frank, Ami Goradia, Michael P Glotzbecker, Wilbur Pan, Leslie S Kersun, Ann Leahey, John P Dormans, John K Choi

Author Affiliations

1: Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.

Articles by these authors

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol (2013) 3.04

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci U S A (2008) 2.99

Event-horizon-scale structure in the supermassive black hole candidate at the Galactic Centre. Nature (2008) 2.97

Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. J Clin Oncol (2012) 2.96

Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol (2012) 2.95

miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J (2010) 2.47

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 2.30

The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL. Blood (2005) 2.25

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial. Lancet Oncol (2012) 2.25

Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol (2012) 2.21

Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. J Proteome Res (2011) 2.17

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2012) 2.16

A mechanism for gene-environment interaction in the etiology of congenital scoliosis. Cell (2012) 2.08

Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era. Am J Ophthalmol (2013) 2.02

Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg (2005) 1.91

The International Classification of Retinoblastoma predicts chemoreduction success. Ophthalmology (2006) 1.86

Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia. Blood (2010) 1.86

Genome-wide association studies of adolescent idiopathic scoliosis suggest candidate susceptibility genes. Hum Mol Genet (2011) 1.83

Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) (2005) 1.81

Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation. Blood (2008) 1.78

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol (2007) 1.73

Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood (2013) 1.73

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2013) 1.72

Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. Blood (2011) 1.70

NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J (2009) 1.66

Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev (2007) 1.65

Comparison of titanium elastic nails with traction and a spica cast to treat femoral fractures in children. J Bone Joint Surg Am (2004) 1.63

The Spinal Appearance Questionnaire: results of reliability, validity, and responsiveness testing in patients with idiopathic scoliosis. Spine (Phila Pa 1976) (2007) 1.60

Neurophysiological detection of impending spinal cord injury during scoliosis surgery. J Bone Joint Surg Am (2007) 1.54

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 1.52

The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood (2011) 1.51

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol (2010) 1.50

EBV-positive diffuse large B-cell lymphoma of the elderly. Blood (2013) 1.49

A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia. Clin Cancer Res (2008) 1.48

Trisomy 21 enhances human fetal erythro-megakaryocytic development. Blood (2008) 1.47

What is the current status of global health activities and opportunities in US orthopaedic residency programs? Clin Orthop Relat Res (2013) 1.39

CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis. Leuk Lymphoma (2013) 1.38

Establishment of an 11-year cohort of 8733 pediatric patients hospitalized at United States free-standing children's hospitals with de novo acute lymphoblastic leukemia from health care administrative data. Med Care (2014) 1.38

Factors distinguishing septic arthritis from transient synovitis of the hip in children. A prospective study. J Bone Joint Surg Am (2006) 1.35

Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood (2007) 1.33

Etiology of child mortality in Goroka, Papua New Guinea: a prospective two-year study. Bull World Health Organ (2002) 1.33

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood (2004) 1.32

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Mol Cancer (2008) 1.32

Placental growth retardation due to loss of imprinting of Phlda2. Mech Dev (2004) 1.32

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood (2006) 1.31

Occipitalization of the atlas in children. Morphologic classification, associations, and clinical relevance. J Bone Joint Surg Am (2007) 1.30

Os odontoideum revisited: the case for a multifactorial etiology. Spine (Phila Pa 1976) (2006) 1.30

An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest (2007) 1.30

Jet-launching structure resolved near the supermassive black hole in M87. Science (2012) 1.28

Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer (2011) 1.26

Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies. Blood (2012) 1.25

Molecular hallmarks of endogenous chromatin complexes containing master regulators of hematopoiesis. Mol Cell Biol (2008) 1.23

Phospholipase cbeta is critical for T cell chemotaxis. J Immunol (2007) 1.22

Building consensus: development of a Best Practice Guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery. J Pediatr Orthop (2013) 1.21

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica (2012) 1.21

Modern surgical treatment of primary aneurysmal bone cyst of the spine in children and adolescents. J Pediatr Orthop (2005) 1.19

EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation. Mod Pathol (2012) 1.16

Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr Res (2004) 1.14

Langerhans cell histiocytosis of the spine in children. Long-term follow-up. J Bone Joint Surg Am (2004) 1.13

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res (2014) 1.13

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer (2014) 1.13

A cautionary tale: dosing chemotherapy in infants with retinoblastoma. J Clin Oncol (2012) 1.11

The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr/abl. Blood (2002) 1.10

miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood (2011) 1.10

Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood (2014) 1.10

The diagnostic accuracy of MRI versus CT imaging for osteoid osteoma in children. Clin Orthop Relat Res (2005) 1.10

Detection of human herpesvirus DNA in Kikuchi-Fujimoto disease and reactive lymphoid hyperplasia. Int J Clin Exp Pathol (2008) 1.09

Traumatic atlanto-occipital dislocation in children. J Bone Joint Surg Am (2005) 1.08

Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses. Dev Dyn (2013) 1.08

Results of a minimally invasive technique for treatment of unicameral bone cysts. Clin Orthop Relat Res (2009) 1.07

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood (2013) 1.06

Phosphoinositide binding by the pleckstrin homology domains of Ipl and Tih1. J Biol Chem (2002) 1.05

Giant cell tumor of tendon sheath: largest single series in children. J Pediatr Orthop (2007) 1.05

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes. J Immunol (2008) 1.05

Xenopus laevis POU91 protein, an Oct3/4 homologue, regulates competence transitions from mesoderm to neural cell fates. EMBO J (2006) 1.04

A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol Med (2012) 1.03

Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology (2009) 1.02

Painless ankle mass in a 12-year-old boy. Clin Orthop Relat Res (2004) 1.02

Loss of PIP5KIbeta demonstrates that PIP5KI isoform-specific PIP2 synthesis is required for IP3 formation. Proc Natl Acad Sci U S A (2008) 1.02

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. Blood (2004) 1.02

High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma. Am J Surg Pathol (2012) 1.01

An atypical presentation of Langerhans cell histiocytosis of the cervical spine in a child. Spine (Phila Pa 1976) (2003) 1.00

Limb sparing surgery for pediatric musculoskeletal tumors. Pediatr Blood Cancer (2004) 1.00

Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am (2006) 1.00

CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. J Immunol (2007) 1.00

Primary musculoskeletal Langerhans cell histiocytosis in children: an analysis for a 3-decade period. J Pediatr Orthop (2009) 0.99

Scoliotic curve patterns in patients with Chiari I malformation and/or syringomyelia. Spine (Phila Pa 1976) (2003) 0.99

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma. Pediatr Blood Cancer (2005) 0.99

Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm. J Clin Invest (2014) 0.99

The 50 most cited articles in pediatric orthopedic surgery. J Pediatr Orthop B (2012) 0.99

Comparison of Cobb angle measurement of scoliosis radiographs with preselected end vertebrae: traditional versus digital acquisition. Spine (Phila Pa 1976) (2007) 0.99

Inhibition of the p53 E3 ligase HDM-2 induces apoptosis and DNA damage--independent p53 phosphorylation in mantle cell lymphoma. Clin Cancer Res (2008) 0.99

Transcranial electric motor evoked potential monitoring during spine surgery: is it safe? Spine (Phila Pa 1976) (2011) 0.99

Antimicrobial behavior of polyelectrolyte multilayer films containing cetrimide and silver. Biomacromolecules (2005) 0.98

A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer (2011) 0.98

Congenital osseous anomalies of the upper cervical spine. J Bone Joint Surg Am (2008) 0.98

Esophagitis dissecans superficialis associated with celiac disease. Gastrointest Endosc (2003) 0.98

Osteoblastoma in the skeletally immature. J Pediatr Orthop (2008) 0.96